Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525

Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
free
free
  English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |   
lüll Perioperative hypertension management Varon J; Marik PEVasc Health Risk Manag 2008[]; 4 (3): 615-27Perioperative hypertension is commonly encountered in patients that undergo surgery. While attempts have been made to standardize the method to characterize the intraoperative hemodynamics, these methods still vary widely. In addition, there is a lack of consensus concerning treatment thresholds and appropriate therapeutic targets, making absolute recommendations about treatment difficult. Nevertheless, perioperative hypertension requires careful management. When treatment is necessary, therapy should be individualized for the patient. This paper reviews the pharmacologic agents and strategies commonly used in the management of perioperative hypertension.|*Surgical Procedures, Operative[MESH]|Adrenergic beta-Antagonists/pharmacology[MESH]|Antihypertensive Agents/*pharmacology/therapeutic use[MESH]|Enalaprilat/pharmacology/therapeutic use[MESH]|Fenoldopam/pharmacology/therapeutic use[MESH]|Hemodynamics/drug effects[MESH]|Humans[MESH]|Hydralazine/pharmacology/therapeutic use[MESH]|Hypertension/*drug therapy/epidemiology[MESH]|Incidence[MESH]|Labetalol/administration & dosage/pharmacology[MESH]|Nicardipine/pharmacology/therapeutic use[MESH]|Nitroglycerin/pharmacology[MESH]|Nitroprusside/pharmacology[MESH]|Perioperative Care[MESH]|Postoperative Complications/*drug therapy[MESH]|Propanolamines/pharmacology[MESH]|Pyridines/pharmacology/therapeutic use[MESH]|Vascular Resistance/drug effects[MESH]|Vasodilator Agents/pharmacology[MESH] |